Literature DB >> 3083979

Reasons for poor prognosis in British patients with cutaneous malignant melanoma.

V R Doherty, R M MacKie.   

Abstract

One hundred and twenty five patients presenting in the west of Scotland with primary cutaneous malignant melanoma answered a detailed questionnaire to establish whether there was any evidence of inappropriate delay in receiving surgical treatment for a new or changing pigmented lesion. The survey was carried out because of the relatively high proportion of patients in Scotland with melanoma presenting with primary lesions categorised as "thick, poor prognosis" and the poor five year survival figures as compared with many other countries. Of the 125 patients questioned, only 20 (16%) had received appropriate surgical treatment within three months of becoming aware of a suspicious cutaneous pigmented lesion; 63 (50%) had received surgical treatment three to 12 months after first noticing such a change, and in 42 cases (34%) this interval was over one year. In 102 of 105 patients in whom the interval exceeded three months the patient alone was responsible for the delay; in only three cases was the family doctor partially at fault. No evidence of delay by the hospital service was identified. Because of these findings a public education campaign was launched in the west of Scotland in June 1985 with the aim of improving recognition of early malignant melanoma. In the next six months the proportion of patients in the west of Scotland with primary melanomas categorised as "thin, good prognosis" had risen from 38% to 62%, and the proportion with tumours categorised as "thick, poor prognosis" had fallen from 34% to 15%.

Entities:  

Mesh:

Year:  1986        PMID: 3083979      PMCID: PMC1339918          DOI: 10.1136/bmj.292.6526.987

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

2.  Malignant melanoma in Scotland 1979-1983.

Authors:  R M MacKie; J F Smyth; D S Soutar; K C Calman; A C Watson; J A Hunter; K M McLaren; J B MacGillivray; J L McPhie; R Rankin
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Evaluation of prognosis in Stage I cutaneous melanoma.

Authors:  A Breslow; S D Macht
Journal:  Plast Reconstr Surg       Date:  1978-03       Impact factor: 4.730

  3 in total
  20 in total

1.  Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study.

Authors:  Rona M MacKie; Caroline A Bray; Joyce A Leman
Journal:  BMJ       Date:  2003-02-15

2.  Screening for skin cancer.

Authors:  R K Curley; R A Marsden; F G Taylor
Journal:  BMJ       Date:  1990-07-14

3.  Effect of rapid referral on thickness of melanomas.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

Review 4.  Non-melanoma skin cancer.

Authors:  I Harvey; D Shalom; R M Marks; S J Frankel
Journal:  BMJ       Date:  1989-11-04

5.  Audit of public education campaign to encourage earlier detection of malignant melanoma.

Authors:  R M MacKie; D Hole
Journal:  BMJ       Date:  1992-04-18

6.  Experience of a public education programme on early detection of cutaneous malignant melanoma.

Authors:  V R Doherty; R M MacKie
Journal:  BMJ       Date:  1988-08-06

Review 7.  Role of primary care in the prevention of malignant melanoma.

Authors:  N Johnson; D Mant; J Newton; P L Yudkin
Journal:  Br J Gen Pract       Date:  1994-11       Impact factor: 5.386

8.  Prevention, early detection and team management of skin cancer in primary care: contribution to The health of the nation objectives.

Authors:  A Jackson
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

9.  Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia.

Authors:  D R English; B K Armstrong
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

Review 10.  Epidemiology of invasive cutaneous melanoma.

Authors:  R M MacKie; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.